Business3 weeks ago
Relay Therapeutics Upgraded to Buy Amid Valuation Recovery Efforts
Investment firm Seeking Alpha has upgraded its rating for Relay Therapeutics (NASDAQ: RLAY) to a “buy” following a notable decline in the company’s valuation that analysts...